HOME Top Market Reports Neurovascular Devices/Interventional Neurology Market by Product (Embolic Coils, Stents, Neurothrombectomy Devices, Microcatheters, Balloon Occlusion Devices, Flow Diversion Devices, Clot Retrievers), Pathology (Aneurysm, AVM) - Global Forecasts to 2021

Neurovascular Devices/Interventional Neurology Market by Product (Embolic Coils, Stents, Neurothrombectomy Devices, Microcatheters, Balloon Occlusion Devices, Flow Diversion Devices, Clot Retrievers), Pathology (Aneurysm, AVM) - Global Forecasts to 2021

By: marketsandmarkets.com
Publishing Date: February 2017
Report Code: MD 1310

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global interventional neurology/neurovascular devices market is estimated to reach USD 2.62 Billion by 2021, at a CAGR of 8.6% during the forecast period. The large patient population base with target diseases, ongoing product development & commercialization, favorable medical reimbursements, expansion of healthcare infrastructure across emerging markets, and growing market demand for effective neurovascular devices are some key factors driving the growth of the market.

Asia-Pacific (comprising China, India, Japan, and the Rest of Asia-Pacific) is the fastest-growing region of the market, owing to factors such as the presence of a large patient population base for target diseases, rising awareness among neurosurgeons related to the benefits offered by interventional neurology devices, ongoing government initiatives to modernize & expand healthcare infrastructure, and increasing adoption of neurovascular devices due to decreasing product price (owing to increasingly localized manufacturing and strengthening of distribution networks).

Emerging markets (such as China and India) are offering high growth opportunities for market players operating in the interventional neurology industry, growth in target patient population, increase in healthcare expenditure, and favorable regulatory policies are the key factors driving the demand for neurovascular products in emerging nations. In order to leverage the high growth opportunities in these emerging nations, leading market players are expanding their presence in these countries.

As of 2015, Stryker Corporation (U.S.) held the leading position in the global market. Over the past three years, the company has adopted product launches and product enhancements; strategic acquisitions; and agreements & collaborations as its key business strategies to ensure its dominance in this market.

Medtronic plc (Ireland), Johnson & Johnson (U.S.), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), Abbott Laboratories (U.S.), Merit Medical Systems, Inc. (U.S.), W. L. Gore & Associates, Inc. (U.S.), and MicroPort Scientific Corporation (China) are few other key players operating in the market.

Target Audience

  • Healthcare service providers (Hospitals and surgical centers)
  • Non-government organizations
  • Government regulatory authorities
  • Research laboratories and academic institutes
  • Clinical research organizations (CROs)
  • Research and development companies
  • Market research and consulting firms

To know about the assumptions considered for the study, download the pdf brochure

Scope of the report

This research report categorizes the neurovascular devices/interventional neurology market into the following segments:

Neurovascular Devices/Interventional Neurology Market, by Products

  • Aneurysm Coiling & Embolization Devices
  • Embolic Coils
    • Bare Detachable Coils
    • Coated Detachable Coils
  • Flow Diversion Devices
  • Liquid Embolic Agents
  • Cerebral Balloon Angioplasty & Stenting Systems
  • Carotid Artery Stents
  • Embolic Protection Systems
    • Distal Filter Devices
    • Balloon Occlusion Devices
  • Support Devices
  • Microcatheters
  • Microguidewires
  • Neurothrombectomy Devices
  • Clot Retrievers
  • Suction and Aspiration Devices
  • Snares

Neurovascular Devices/Interventional Neurology Market, by Disease Pathology

  • Ischemic Stroke
  • Cerebral Aneurysms
  • Arteriovenous Malformations and Fistulas
  • Other Diseases

Neurovascular Devices/Interventional Neurology Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • RoE
  • Asia-Pacific
    • Japan
    • China
    • India
    • RoAPAC
  • Rest of the World

Available Customozations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for interventional neurology market report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top five companies

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 16)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Breakdown of Primaries
    2.2 Opportunity Indicators
           2.2.1 Target Disease Prevalence
           2.2.2 Rising Geriatric Population
           2.2.3 Number of Hospitals and Surgical Centers
           2.2.4 Healthcare Expenditure
           2.2.5 Number of Clinical Researches
    2.3 Market Size Estimation
           2.3.1 Bottom-Up Approach
           2.3.2 Top-Down Approach
    2.4 Market Breakdown and Data Triangulation
    2.5 Research Assumptions
           2.5.1 Assumptions

3 Executive Summary (Page No. - 35)

4 Premium Insights (Page No. - 40)
    4.1 Neurovascular Devices/Interventional Neurology Market Overview
    4.2 Global Neurovascular Devices/Interventional Neurology Product Market, By Region (2016 vs 2021)
    4.3 Global Neurovascular Devices/Interventional Neurology Product Market (2016 vs 2021)
    4.4 Global Neurovascular Devices/Interventional Neurology Market, By Disease Pathology, By Region (2016-2021)
    4.5 Neurovascular Devices/Interventional Neurology Market, By Country (2016 vs 2021)

5 Market Overview (Page No. - 45)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Key Market Drivers
                    5.2.1.1 Large Target Patient Population
                    5.2.1.2 Ongoing Product Development and Commercialization
                    5.2.1.3 Favorable Medical Reimbursements
                    5.2.1.4 Expansion of Healthcare Infrastructure Across Emerging Markets
                    5.2.1.5 Growing Market Demand for Effective Neurovascular Devices
           5.2.2 Key Market Restraints
                    5.2.2.1 Stringent Regulatory Scenario
                    5.2.2.2 Dearth of Skilled Neurosurgeons
           5.2.3 Key Market Opportunities
                    5.2.3.1 Increasing Number of Research Activities in the Field of Neurovascular Therapies
                    5.2.3.2 Rising Demand for Minimally Invasive Neurosurgical Procedures
    5.3 Ongoing Clinical Studies
           5.3.1 Embolization Coiling Procedures
           5.3.2 Carotid Artery Stenting Procedures
           5.3.3 Embolic Protection Procedures
           5.3.4 Flow Diversion Procedures
           5.3.5 Supporting Techniques
           5.3.6 Neurothrombectomy Procedures

6 Industry Insights (Page No. - 74)
    6.1 Introduction
    6.2 Supply Chain Analysis
    6.3 Porter’s Five Forces Analysis
    6.4 Industry Trends
           6.4.1 Increasing Surgeon’s Awareness Related to Benefits of Stereotactic Framework Procedures in Neurosurgeries
           6.4.2 Channel Optimization

7 Neurovascular Devices/Interventional Neurology Market, By Product (Page No. - 78)
    7.1 Introduction
    7.2 Aneurysm Coiling & Embolization Devices
           7.2.1 Embolic Coils
                    7.2.1.1 Bare Detachable Coils
                    7.2.1.2 Coated Detachable Coils
           7.2.2 Flow Diversion Devices
           7.2.3 Liquid Embolic Agents
    7.3 Cerebral Balloon Angioplasty and Stenting Systems
           7.3.1 Carotid Artery Stents
           7.3.2 Embolic Protection Systems
                    7.3.2.1 Distal Filter Devices
                    7.3.2.2 Balloon Occlusion Devices
    7.4 Support Devices
           7.4.1 Microcatheters
           7.4.2 Microguidewires
    7.5 Neurothrombectomy Devices
           7.5.1 Clot Retrieval Devices
           7.5.2 Suction and Aspiration Devices
           7.5.3 Snares

8 Global Neurovascular Devices/Interventional Neurology Market, By Disease Pathology (Page No. - 110)
    8.1 Introduction
    8.2 Ischemic Strokes
    8.3 Cerebral Aneurysms
    8.4 Arteriovenous Malformation and Fistulas
    8.5 Other Disease Pathologies

9 Neurovascular Devices/Interventional Neurology Market, By Region (Page No. - 117)
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 France
           9.3.3 U.K.
           9.3.4 Rest of Europe
    9.4 Asia-Pacific
           9.4.1 Japan
           9.4.2 China
           9.4.3 India
           9.4.4 Rest of Asia-Pacific
    9.5 Rest of the World

10 Competitive Landscape (Page No. - 144)
     10.1 Overview
     10.2 Market Share Analysis
     10.3 Competitive Scenario
     10.4 Recent Developments
             10.4.1 Product Launches
             10.4.2 Strategic Acquisitions
             10.4.3 Expansions
             10.4.4 Agreements and Collaborations
             10.4.5 Other Developments

11 Company Profiles (Page No. - 153)
(Company at A Glance, Recent Financials, Products & Services, Strategies & Insights, & Recent Developments)*
     11.1 Introduction
             11.1.1 Geographic Benchmarking
     11.2 Stryker Corporation
     11.3 Medtronic PLC
     11.4 Johnson & Johnson
     11.5 Terumo Corporation
     11.6 Penumbra, Inc.
     11.7 Boston Scientific Corporation
     11.8 Microport Scientific Corporation
     11.9 Merit Medical Systems, Inc.
     11.10 W.L. Gore & Associates, Inc.
     11.11 Abbott Laboratories

*Details on Company at A Glance, Recent Financials, Products & Services, Strategies & Insights, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 182)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Introducing RT: Real-Time Market Intelligence
     12.5 Available Customizations
     12.6 Related Reports
     12.7 Author Details


List of Tables (100 Tables)

Table 1 Embolization Coils: Ongoing Clinical Trials (As of December 2016)
Table 2 Carotid Stents: Ongoing Clinical Trials (As of December 2016)
Table 3 Distal Filter and Balloon Occlusion Catheters: Ongoing Clinical Trials (As of December 2016)
Table 4 Flow Diversion Devices: Ongoing Clinical Trials (As of December 2016)
Table 5 Microcatheters: Ongoing Clinical Trials (As of December 2016)
Table 6 Clot Retrieval, Suction, and Aspiration Devices: Ongoing Clinical Trials (As of December 2016)
Table 7 Global Interventional Neurology/Neurovascular Devices Market Size, By Product, 2014–2021 (USD Million)
Table 8 Global Interventional Neurology/Neurovascular Devices Market Size, By Region, 2014–2021 (USD Million)
Table 9 Global Neurovascular Devices/Interventional Neurology Market Size, By Product, 2014–2021 (Units)
Table 10 Global Aneurysm Coiling & Embolization Devices Market Size, By Type, 2014–2021 (USD Million)
Table 11 Global Aneurysm Coiling & Embolization Devices Market Size, By Type, 2014–2021 (Units)
Table 12 Global Aneurysm Coiling & Embolization Devices Market Size, By Region, 2014–2021 (USD Million)
Table 13 Global Aneurysm Coiling & Embolization Devices Market Size for Embolic Coils Market Size, By Type, 2014–2021 (USD Million)
Table 14 Global Aneurysm Coiling & Embolization Devices Market Volume for Embolic Coils, By Type, 2014–2021 (Units)
Table 15 Aneurysm Coiling & Embolization Devices Market Size for Embolic Coils, By Region, 2014–2021 (USD Million)
Table 16 Aneurysm Coiling & Embolization Devices Market Size for Bare Detachable Coils, By Region, 2014–2021 (USD Million)
Table 17 Aneurysm Coiling & Embolization Devices Market Volume for Bare Detachable Coils, By Region, 2014–2021 (Units)
Table 18 Aneurysm Coiling & Embolization Devices Market Size for Coated Detachable Coils, By Region, 2014–2021 (USD Million)
Table 19 Aneurysm Coiling & Embolization Devices Market Volume for Coated Detachable Coils, By Region, 2014–2021 (Units)
Table 20 Aneurysm Coiling & Embolization Devices Market Size for Flow Diversion Devices, By Region, 2014–2021 (USD Million)
Table 21 Aneurysm Coiling & Embolization Devices Market Volume for Flow Diversion Devices, By Region, 2014–2021 (Units)
Table 22 Aneurysm Coiling & Embolization Devices Market Size for Liquid Embolic Agents, By Region, 2014–2021 (USD Million)
Table 23 Aneurysm Coiling & Embolization Devices Market Volume for Liquid Embolic Agents, By Region, 2014–2021 (Units)
Table 24 Global Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Type, 2014–2021 (USD Million)
Table 25 Global Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Type, 2014–2021 (Units)
Table 26 Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Region, 2014–2021 (USD Million)
Table 27 Cerebral Balloon Angioplasty and Stenting Systems Market Size for Carotid Artery Stents, By Region, 2014–2021 (USD Million)
Table 28 Cerebral Balloon Angioplasty and Stenting Systems Market Volume for Carotid Artery Stents, By Region, 2014–2021 (Units)
Table 29 Global Cerebral Balloon Angioplasty and Stenting Systems Market Size for Embolic Protection Systems, By Type, 2014–2021 (USD Million)
Table 30 Global Cerebral Balloon Angioplasty and Stenting Systems Market Volume for Embolic Protection Systems, By Type, 2014–2021 (Units)
Table 31 Cerebral Balloon Angioplasty and Stenting Systems Market Size for Embolic Protection Systems, By Region, 2014–2021 (USD Million)
Table 32 Cerebral Balloon Angioplasty and Stenting Systems Market Size for Distal Filter Devices, By Region, 2014–2021 (USD Million)
Table 33 Cerebral Balloon Angioplasty and Stenting Systems Market Volume for Distal Filter Devices, By Region, 2014–2021 (Units)
Table 34 Cerebral Balloon Angioplasty and Stenting Systems Market Size for Balloon Occlusion Devices, By Region, 2014–2021 (USD Million)
Table 35 Cerebral Balloon Angioplasty and Stenting Systems Market Volume for Balloon Occlusion Devices, By Region, 2014–2021 (Units)
Table 36 Global Neurovascular and Interventional Neurology Support Devices Market Size, By Type, 2014–2021 (USD Million)
Table 37 Global Neurovascular and Interventional Neurology Support Devices Market Size, By Type, 2014–2021 (Units)
Table 38 Neurovascular and Interventional Neurology Support Devices Market Size, By Region, 2014–2021 (USD Million)
Table 39 Microcatheters Market Size, By Region, 2014–2021 (USD Million)
Table 40 Microcatheters Market Size, By Region, 2014–2021 (Units)
Table 41 Microguidewires Market Size, By Region, 2014–2021 (USD Million)
Table 42 Microguidewires Market Size, By Region, 2014–2021 (Units)
Table 43 Global Neurothrombectomy Devices Market Size, By Type, 2014–2021 (USD Million)
Table 44 Global Neurothrombectomy Devices Market Size, By Type, 2014–2021 (Units)
Table 45 Neurothrombectomy Devices Market Size, By Region, 2014–2021 (USD Million)
Table 46 Neurothrombectomy Clot Retrieval Devices Market Size, By Region, 2014–2021 (USD Million)
Table 47 Neurothrombectomy Clot Retrieval Devices Market Size, By Region, 2014–2021 (Units)
Table 48 Neurothrombectomy Suction & Aspiration Devices Market Size, By Region, 2014–2021 (USD Million)
Table 49 Neurothrombectomy Suction & Aspiration Devices Market Size, By Region, 2014–2021 (Units)
Table 50 Neurothrombectomy Snares Market Size, By Region, 2014–2021 (USD Million)
Table 51 Neurothrombectomy Snares Market Size, By Region, 2014–2021 (Units)
Table 52 Global Neurovascular Devices/Interventional Neurology Market Size, By Disease Pathology, 2014–2021 (USD Million)
Table 53 Globalneurovascular Devices/Interventional Neurology Disease Pathology Market Size, By Region, 2014–2021 (USD Million)
Table 54 Neurovascular Devices/Interventional Neurology Market Size for Ischemic Strokes, By Region, 2014–2021 (USD Million)
Table 55 Neurovascular Devices/Interventional Neurology Market Size for Cerebral Aneurysms, By Region, 2014–2021 (USD Million)
Table 56 Neurovascular Devices/Interventional Neurology Market Size for Arteriovenous Malformation and Fistulas, By Region, 2014–2021 (USD Million)
Table 57 Neurovascular Devices/Interventional Neurology Market Size for Other Disease Pathologies, By Region, 2014–2021 (USD Million)
Table 58 Neurovascular Devices/Interventional Neurology Market Size, By Region, 2014–2021 (USD Million)
Table 59 North America: Neurovascular Devices/Interventional Neurology Market Size, By Country, 2014–2021 (USD Million)
Table 60 North America: Neurovascular Devices/Interventional Neurology Market Size, By Products, 2014–2021 (USD Million)
Table 61 North America: Aneurysm Coiling and Embolization Devices Market Size, By Product , 2014–2021 (USD Million)
Table 62 North America: Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Product, 2014–2021 (USD Million)
Table 63 North America: Support Devices Market Size, By Product, 2014–2021 (USD Million)
Table 64 North America: Neurothrombectomy Devices Market Size, By Product, 2014–2021 (USD Million)
Table 65 North America: Neurovascular Devices/Interventional Neurology Market Size, By Disease Pathology, 2014–2021 (USD Million)
Table 66 U.S.: Neurovascular Devices/Interventional Neurology Market Size, By Product, 2014–2021 (USD Million)
Table 67 Canada: Neurovascular Devices/Interventional Neurology Market Size, By Product, 2014–2021 (USD Million)
Table 68 Europe: Neurovascular Devices/Interventional Neurology Market Size, By Country, 2014–2021 (USD Million)
Table 69 Europe: Neurovascular and Interventional Neurology Market Size, By Products, 2014–2021 (USD Million)
Table 70 Europe: Aneurysm Coiling and Embolization Devices Market Size, By Product, 2014–2021 (USD Million)
Table 71 Europe: Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Product , 2014–2021 (USD Million)
Table 72 Europe: Support Devices Market Size, By Product , 2014–2021 (USD Million)
Table 73 Europe: Neurothrombectomy Devices Market Size, By Product, 2014–2021 (USD Million)
Table 74 Europe: Neurovascular and Interventional Neurology Market Size, By Disease Pathology, 2014–2021 (USD Million)
Table 75 Germany: Neurovascular and Interventional Neurology Market Size, By Product, 2014–2021 (USD Million)
Table 76 France: Neurovascular and Interventional Neurology Market Size, By Product, 2014–2021 (USD Million)
Table 77 U.K.: Neurovascular and Interventional Neurology Market Size, By Product, 2014–2021 (USD Million)
Table 78 RoE: Neurovascular and Interventional Neurology Market Size, By Product, 2014–2021 (USD Million)
Table 79 Asia-Pacific: Neurovascular Devices/ Interventional Neurology Market Size, By Country, 2014–2021 (USD Million)
Table 80 Asia-Pacific: Neurovascular Devices/ Interventional Neurology Market Size, By Products, 2014–2021 (USD Million)
Table 81 Asia-Pacific: Aneurysm Coiling and Embolization Devices Market Size, By Product , 2014–2021 (USD Million)
Table 82 Asia-Pacific: Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Product , 2014–2021 (USD Million)
Table 83 Asia-Pacific: Support Devices Market Size, By Product, 2014–2021 (USD Million)
Table 84 Asia-Pacific: Neurothrombectomy Devices Market Size, By Product, 2014–2021 (USD Million)
Table 85 Asia-Pacific: Neurovascular Devices/ Interventional Neurology Market Size, By Pathology, 2014–2021 (USD Million)
Table 86 Japan: Interventional Neurology Market Size, By Technology, 2014–2021 (USD Million)
Table 87 China: Neurovascular Devices/ Interventional Neurology Market Size, By Technology, 2014–2021 (USD Million)
Table 88 India: Neurovascular Devices/Interventional Neurology Market Size, By Technology, 2014–2021 (USD Million)
Table 89 RoAPAC: Neurovascular Devices/Interventional Neurology Market Size, By Technology, 2014–2021 (USD Million)
Table 90 RoW: Interventional Neurology Market Size, By Products, 2014–2021 (USD Million)
Table 91 RoW: Aneurysm Coiling and Embolization Devices Market Size, By Product Type, 2014–2021 (USD Million)
Table 92 RoW: Cerebral Balloon Angioplasty and Stenting Systems Market Size, By Product, 2014–2021 (USD Million)
Table 93 RoW: Support Devices Market Size, By Product, 2014–2021 (USD Million)
Table 94 RoW: Neurothrombectomy Devices Market Size, By Product, 2014–2021 (USD Million)
Table 95 RoW: Neurothrombectomy Devices Market Size, By Disease Pathology, 2014–2021 (USD Million)
Table 96 Top Product Launches (2013–2016)
Table 97 Top Strategic Acquisitions (2013–2016)
Table 98 Top Expansions (2013–2016)
Table 99 Top Agreements and Collaborations (2013–2016)
Table 100 Other Developments (2013–2016)


List of Figures (52 Figures)

Figure 1 Global Neurovascular Devices?Interventional Neurology Market Segmentation
Figure 2 Research Design
Figure 3 Prevalence of Stroke By Country: as of 2015
Figure 4 Increase in Geriatric Population: By Country (2010–2015)
Figure 5 Increase in the Proportion of Geriatric Individuals in the Overall Population: By Country (2011–2030)
Figure 6 Percentage Increase in Geriatric Population, By Region (1980-2010 vs 2010–2040)
Figure 7 Healthcare Expenditure Across Major Countries: 2000 vs 2014
Figure 8 Healthcare Expenditure Across Major Regions: 2000 vs 2014
Figure 9 Healthcare Spending Matrix: Key Markets (2014)
Figure 10 Bottom-Up Approach
Figure 11 Top-Down Approach
Figure 12 Data Triangulation
Figure 13 Assumptions of the Research Study
Figure 14 Global Neurovascular Devices/Interventional Neurology Market, By Product (2016 vs 2021)
Figure 15 Global Neurovascular Devices/Interventional Neurology Market, By Pathology (2016 vs 2021)
Figure 16 Global Neurovascular Devices/Interventional Neurology Market, By Region (2016 vs 2021)
Figure 17 North America to Dominate Neurovascular Devices/Interventional Neurology Industry During the Forecast Period
Figure 18 Growing Target Patient Population to Propel Market Demand for Interventional Neurology Products During the Forecast Period
Figure 19 Aneurysm Coiling & Embolization Devices Segment to Dominate Interventional Neurology Product Market Till 2021
Figure 20 Embolic Coils to Be Highest Contributing Product Segment of Interventional Neurology Market During 2016-2021 (USD Million)
Figure 21 Ischemic Stroke Segment to Lead the Market Demand Growth for Interventional Neurology Products During 2016-2021
Figure 22 China and India Poised to Be the Fastest Growing Countries in Interventional Neurology Market During 2016-2021
Figure 23 Neurovascular Devices/Interventional Neurology Market: Drivers, Restraints, Opportunities, and Challenges
Figure 24 Proportion of Geriatric Population to Total Population, By Country, (2012 vs 2020)
Figure 25 Global Trend in Government Healthcare Expenditure: Developed vs Developing Countries (2010 vs 2014)
Figure 26 Ongoing Clinical Trials in the Field of Interventional Neurology Across the Globe (As of December 2016)
Figure 27 Supply Chain Analysis: Neurovascular Devices/Interventional Neurology Industry (As of 2016)
Figure 28 Porter’s Five Forces Analysis (2016): Growing Adoption of Neurovascular Products is Translating Into Higher Market Demand
Figure 29 Cerebral Balloon Angioplasty & Stenting Systems to Witness Highest Market Growth During 2016-2021
Figure 30 Embolic Coils Segment is Expected to Lead Aneurysm Coiling and Embolization Devices Market Growth During the Forecast Period
Figure 31 Carotid Artery Stents Segment to Witness Highest Growth in the Cerebral Balloon Angioplasty & Stenting Systems Market Till 2021
Figure 32 Microcatheters are Expected to Hold the Largest Share of Supporting Devices Market During the Forecast Period
Figure 33 Clot Retrievers to Witness Significant Market Growth in Overall Neurothrombectomy Devices Industry During 2016-2021
Figure 34 Ischemic Stroke is Poised to Be the Fastest Growing Disease Pathology Segment in Neurovascular Devices/Interventional Neurology Market During 2016-2021
Figure 35 North America is Expected to Dominate Interventional Neurology Market for Ischemic Stroke Treatment Till 2021
Figure 36 North America: Neurovascular Devices/Interventional Neurology Market Snapshot
Figure 37 Europe: Neurovascular Devices/Interventional Neurology Market Snapshot
Figure 38 Asia-Pacific: Neurovascular Devices/Interventional Neurology Market Snapshot
Figure 39 Rest of the World: Neurovascular Devices/Interventional Neurology Market Snapshot
Figure 40 Product Launches & Commercialization: Key Growth Strategy Adopted By Majority of Market Players From 2013 to 2016
Figure 41 Global Neurovascular Devices/Interventional Neurology Market Share, Key Player (2015)
Figure 42 Growing Number of Product Launches and Enhancements is Driving the Market Growth
Figure 43 Geographic Revenue Mix of the Top Four Market Players
Figure 44 Stryker Corporation: Company Snapshot (2015)
Figure 45 Medtronic PLC: Company Snapshot (2015)
Figure 46 Johnson & Johnson: Company Snapshot (2015)
Figure 47 Terumo Corporation: Company Snapshot (2015)
Figure 48 Penumbra, Inc.: Company Snapshot (2015)
Figure 49 Boston Scientific Corporation: Company Snapshot (2015)
Figure 50 Microport Scientific Corporation: Company Snapshot (2015)
Figure 51 Merit Medical Systems, Inc.: Company Snapshot (2015)
Figure 52 Abbott Laboratories: Company Snapshot (2015)

The global neurovascular devices/interventional neurology market is expected to reach a value of USD 2.62 Billion by 2021; growing at a CAGR of 8.6% during 2016-2021. A number of factors such as growing target patient population, ongoing product development & commercialization, favorable medical reimbursements, expansion of healthcare infrastructure across emerging markets, growing market demand for effective neurovascular devices, increasing number of researches in the field of neurovascular therapies, rising demand for minimally invasive neurosurgical procedures, and increasing awareness among neurosurgeons about minimally invasive surgical procedures. However, dearth of skilled neurosurgeons and stringent regulatory policies are the key challenges faced by leading players in the global neurovascular devices/interventional neurology market.

On the basis of products, the neurovascular devices/interventional neurology market is segmented into aneurysm coiling and embolization devices, cerebral balloon angioplasty and stenting systems, support devices, and neurothrombectomy devices. The aneurysm coiling and embolization devices segment is expected to hold the largest share of the interventional neurology market in 2016. The large market share of this segment can be attributed to the growing end-user preference for minimally invasive neurosurgical procedures and increasing market availability of embolic coils for neurovascular treatment.

On the basis of pathology, the neurovascular devices/interventional neurology market is segmented into ischemic strokes, cerebral aneurysm, arteriovenous malformations & fistulas, and other diseases. The ischemic strokes segment is expected to hold the largest share of the global neurovascular devices/interventional neurology market in 2016. Dominant market position of ischemic strokes segment is attributed to rising prevalence of ischemic stroke (coupled with exposure of larger proportion of global population to major risk factors such as smoking and diabetes), and increasing patient preference for minimally invasive therapeutic neurosurgical technologies.

On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, the global interventional neurology market is expected to be dominated by North America. North American region is expected to dominate the neurovascular devices/interventional neurology market during study period owing to significant adoption of neurovascular devices among neurosurgeons in neurovascular disease treatment, growing number of clinical trials (that aim to evaluate the therapeutic efficacy of neurovascular devices) and significant medical reimbursement available in the U.S. for neurosurgical procedures.

New product launches and enhancements are the key growth strategies adopted by major players to develop their positions in the global neurovascular devices/interventional neurology market. Moreover, strategies such as agreements and collaborations; strategic acquisitions; and market expansions were also adopted by a significant number of market players to strengthen their product portfolios, distribution networks and expand their geographic presence in the global neurovascular devices/interventional neurology market.

As of 2015, Stryker Corporation (U.S.), Medtronic plc (U.S.), Johnson & Johnson (U.S.), and Terumo Corporation (Japan) are the top four players in the market. Other prominent players present in the market include Penumbra, Inc. (U.S.), Abbott Laboratories (U.S.), Merit Medical Systems, Inc. (U.S.), W. L. Gore & Associates, Inc. (U.S.), and MicroPort Scientific Corporation (China), among others.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo